TIDM3DD

RNS Number : 6574H

3D Diagnostic Imaging PLC

01 June 2011

 
 For Immediate Release   1 June 2011

3D Diagnostic Imaging plc

("3D" or the "Company")

(AIM: 3DD)

CORESTRENGTH TO MANAGE CARIESCAN PRO SALES ACTIVITY IN THE USA AND CANADA

Further to the announcement made by the Company on Thursday 12 May 2011, 3D is pleased to announce that its wholly owned subsidiary CarieScan Ltd ("CarieScan") has now entered into an agreement with CoreStrength Inc ("CoreStrength") to manage its sales channel activity in both the USA and Canada (the "Agreement") for the CarieScan PRO (the easy to use hand held device for the early detection and monitoring of dental caries).

CarieScan will continue to work closely on a non-exclusive basis with Patterson Dental, its existing distribution partner in the USA.

CoreStrength, a well established leader in dental sales management, will provide CarieScan with access to an experienced sales team of 22, substantially improving CarieScan's sales reach in those markets. Under the terms of the Agreement, CarieScan will contribute towards the costs of a jointly agreed marketing plan and towards certain costs incurred by CoreStrength in the delivery of its services.

The Agreement provides CarieScan with access to sales coverage for the whole of the North American territory on a predominantly commission only basis enabling the Company to move forward on a significantly more cost effective manner.

As a consequence of entering into the Agreement and of moving away from directly employing sales support staff in the USA and Canada, the Directors believe that a significant proportion of the cost savings identified and referred to in the announcement made by the Company on Thursday 12 May 2011 are now in place.

Commenting on the Agreement Graham Lay, 3D CEO said, "I am delighted to be working with such a professional and experienced team and to achieve comprehensive coverage of the territory on such a cost effective basis."

Glenn Bonagura, Partner of CoreStrength said, "We believe that there is a substantial opportunity to sell the award winning CarieScan PRO to our customer base. We are known in the industry for our understanding of the latest and best dental products as well as our strong distribution network. Over the coming months we aim to build a sustainable competitive advantage for CarieScan across North America, and we look forward to working with the team."

Josh Killian, Director of Marketing for Patterson Dental said, "We know the team at CoreStrength very well. Having a national sales support network in place is a key component for CarieScan to achieve traction with their new product."

ENDS

For further information please contact:

 
 3D Diagnostic Imaging Plc     +44 (0) 1624 679000 
 Graham Lay, CEO 
 Oliver Cooke, CFO 
 
 finnCap                       NOMAD & Broker 
 Geoff Nash                    +44 (0)20 7600 1658 
 Henrik Persson 
 Stephen Norcross (broking) 
 
 Buchanan Communications       +44 (0) 131 226 4427 
 Diane Stewart                 +44 (0) 207 466 5000 
 Carrie Clement

Notes to Editors:

http://www.3ddiagnosticimaging.com/

3D owns the protected rights to a technology platform with a number of significant potential commercial applications. Its first product to market is the CarieScan PROtm.

The CarieScan PROtm measures the presence of tooth decay earlier and more accurately than any other device on the market and is more than 90% accurate in detecting both sound and carious teeth, well ahead of other methods. It detects "hidden" decay, providing dental practitioners with the opportunity to arrest or even reverse decay, driving the trend towards preventative dental care.

The lightweight CarieScan PROtm detection monitor not only offers best-in-class performance for decay detection but also allows easy monitoring of the effect of treatment regimes to show decay advancement or regression, thus enabling dentists to tailor treatment to the needs of the patient at a low cost. The CarieScan PROtm consists of a hand piece and a disposable sensor which is held against the tooth being examined in a process which takes approximately 4 seconds per tooth with the result displayed on the CarieScan PROtm.

For more information on CoreStrength Inc please visit http://www.corestrength.us

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSSWFSFFFSESM

3D Diagnostic (LSE:3DD)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more 3D Diagnostic Charts.
3D Diagnostic (LSE:3DD)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more 3D Diagnostic Charts.